WHO Home Page

Office of the Director-General

World Health Organization
Organisation mondiale de la Santé

UPDATED: Tue May 7 14:30:15 2002

Dr Gro Harlem Brundtland        
Director-General
World Health Organization

Geneva
6 May 2002

   

Global Priorities in Influenza Surveillance and Control

Colleagues,

Welcome to the World Health Organization. I am grateful to you for attending this meeting. We have high hopes of you.

We are all pursuing the same goal. We want to see a big reduction in the unacceptably high morbidity and mortality caused by annual influenza epidemics. I hope that by the time you leave, tomorrow, you will have debated and prepared recommendations for the first Global Agenda on Influenza Prevention and Control. This Agenda should set out priority activities that must be undertaken to reduce influenza-related suffering. It will help the international community prepare for the next pandemic.

The Global Agenda has relevance beyond the World Health Organization. It should provide guidance on best practice to all parties with a stake in influenza activities – for research and development, for national and global surveillance, and for control measures. The Agenda should help those involved in advocacy and fund raising at national and international levels. With your guidance, it can also be a tool to support coordination for regional and global influenza control actions.

I know that most of you have been involved in the preparation of the draft Agenda over the past year. You know that we issued a worldwide call for proposals in June 2001. The result was overwhelming. We received more than 100 contributions from you and other influenza experts. This is a tremendous effort.

Colleagues,

You participate in this meeting as experts. We rely on your scientific and professional expertise - particularly your knowledge about influenza, and about national and international approaches to communicable disease surveillance and control. You represent a wide range of technical, administrative and managerial expertise and come from the public and private sector. Your expertise will make possible the authoritative synthesis of evidence, the building of a science-based consensus, and the development of valid action plans.

Your work these two days will help WHO to sharpen the work of its Global Influenza Programme, improving the links between actions for influenza surveillance and for influenza control.

More than 250 million vaccine doses are produced annually with the influenza strains WHO recommends and makes available to the pharmaceutical industry. Global influenza surveillance and evidence-based recommendations on vaccine content will remain the cornerstone of the Programme's work.

We know that the level of national and international pandemic preparedness is far from satisfactory. And we know that the next influenza pandemic is inevitable.

We are working on better plans for preparedness. We believe they should include guidance on the use of influenza vaccines and antivirals in handling influenza. We need your collaboration and feed-back as we consider how to take forward these preparedness plans before we submit them to our governing bodies.

Colleagues,

We also know that it is very difficult for countries to defend themselves against imported airborne pathogens. Yet most of the influenza Vaccine is to be found in the richer world. There is an acute need for this vaccine in developing countries.

To take forward the global influenza control effort there is a need for up to date knowledge on the burden of influenza illness, the availability of affordable vaccine and current prevention and control policies within developing countries.

WHO is ready to play a critical part in addressing these issues. We will focus on what we do best, seeking our partners who can take on other functions. We will keep a sharp eye on financial implications. We know that we must step up our efforts in some areas - such as data on the influenza burden in developing countries, better pandemic preparedness plans, and strategies for expanding vaccine usage.

I anticipate that WHO will pull together a plan of action and a long-term strategic plan on Global Influenza Surveillance and Control by the end of this year. The Global Agenda on Influenza will certainly be an important document in the preparation of this strategic plan.

The programme to confront Influenza is WHO's oldest. It continues to be much in need. It has shown an ability to deliver results - supporting the multitude of activities implemented by many partners involved in influenza control and surveillance. But more must be done by all of us, working together.

A Global Agenda on Influenza Prevention and Control will bring us all one step closer to our goals of a healthy, more prosperous and secure world.

Thank you again for participating in this meeting. I look forward to the outcome.

Return to Director-General's main page